Figure 4.
Comparison of progression-free survival of patients with stage IIB cervical cancer between different subgroups of (a) PLR, (b) NLR, (c) MLR, (d) BLR, and (e) SIRI.
Comparison of progression-free survival of patients with stage IIB cervical cancer between different subgroups of (a) PLR, (b) NLR, (c) MLR, (d) BLR, and (e) SIRI.